88 related articles for article (PubMed ID: 8855374)
1. Human insulin gene expression in transgenic mice: mutational analysis of the regulatory region.
Itier JM; Douhet P; Desbois P; Joshi RL; Dandoy-Dron F; Jami J; Bucchini D
Differentiation; 1996 Sep; 60(5):309-16. PubMed ID: 8855374
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific expression of the rat insulin 1 gene in vivo requires both the enhancer and promoter regions.
Dandoy-Dron F; Itier JM; Monthioux E; Bucchini D; Jami J
Differentiation; 1995 Apr; 58(4):291-5. PubMed ID: 7641979
[TBL] [Abstract][Full Text] [Related]
3. Chick delta1-crystallin enhancer influences mouse alphaA-crystallin promoter activity in transgenic mice.
Reneker LW; Chen Q; Bloch A; Xie L; Schuster G; Overbeek PA
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4083-90. PubMed ID: 15505059
[TBL] [Abstract][Full Text] [Related]
4. Effect of the rabbit alphas1-casein gene distal enhancer on the expression of a reporter gene in vitro and in vivo.
Pantano T; Jolivet G; Prince S; Menck-Le Bourhis C; Maeder C; Viglietta C; Rival S; Houdebine LM
Biochem Biophys Res Commun; 2002 Jan; 290(1):53-61. PubMed ID: 11779132
[TBL] [Abstract][Full Text] [Related]
5. Quail myoD is regulated by a complex array of cis-acting control sequences.
Pinney DF; de la Brousse FC; Faerman A; Shani M; Maruyama K; Emerson CP
Dev Biol; 1995 Jul; 170(1):21-38. PubMed ID: 7601311
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the contribution of known cis-elements in the mouse cone arrestin gene to its cone-specific expression.
Pickrell SW; Zhu X; Wang X; Craft CM
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3877-84. PubMed ID: 15505032
[TBL] [Abstract][Full Text] [Related]
7. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional control of muscle plasticity: differential regulation of troponin I genes by electrical activity.
Calvo S; Stauffer J; Nakayama M; Buonanno A
Dev Genet; 1996; 19(2):169-81. PubMed ID: 8900050
[TBL] [Abstract][Full Text] [Related]
10. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
11. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice.
Abdullah Abu Musa DM; Kobayashi K; Yasuda I; Iijima M; Christoffels VM; Tomomura M; Horiuchi M; Ohnishi T; Kajihara T; Daikuhara Y; Lamers WH; Saheki T
Mol Genet Metab; 1999 Nov; 68(3):346-56. PubMed ID: 10562461
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the human myeloperoxidase promoter region.
Chumakov AM; Chumakova EA; Chih D; Koeffler HP
Int J Oncol; 2000 Feb; 16(2):401-11. PubMed ID: 10639585
[TBL] [Abstract][Full Text] [Related]
15. Regulatory regions of rat insulin I gene necessary for expression in transgenic mice.
Dandoy-Dron F; Monthioux E; Jami J; Bucchini D
Nucleic Acids Res; 1991 Sep; 19(18):4925-30. PubMed ID: 1923760
[TBL] [Abstract][Full Text] [Related]
16. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
17. Fiber-type specific and position-dependent expression of a transgene in limb muscles.
Spitz F; Benbacer L; Sabourin JC; Salminen M; Chen F; Cywiner C; Kahn A; Chatelet F; Maire P; Daegelen D
Differentiation; 2002 Oct; 70(8):457-67. PubMed ID: 12366383
[TBL] [Abstract][Full Text] [Related]
18. Specific transgene expression in mouse pancreatic beta-cells under the control of the porcine insulin promoter.
Grzech M; Dahlhoff M; Herbach N; Habermann FA; Renner-Müller I; Wanke R; Flaswinkel H; Wolf E; Schneider MR
Mol Cell Endocrinol; 2010 Feb; 315(1-2):219-24. PubMed ID: 19682540
[TBL] [Abstract][Full Text] [Related]
19. Effect of 5'-flanking sequence deletions on expression of the human insulin gene in transgenic mice.
Fromont-Racine M; Bucchini D; Madsen O; Desbois P; Linde S; Nielsen JH; Saulnier C; Ripoche MA; Jami J; Pictet R
Mol Endocrinol; 1990 May; 4(5):669-77. PubMed ID: 2274051
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of size and copy number of the human insulin gene in transfected rat islet tumor cell clones.
Andersen LC; Michelsen B; Madsen OD
Exp Clin Endocrinol; 1989 May; 93(2-3):272-6. PubMed ID: 2570709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
